Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Cited In for PubMed (Select 12466116)

1.

Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.

Sheu MJ, Hsieh MJ, Chiang WL, Yang SF, Lee HL, Lee LM, Yeh CB.

PLoS One. 2015 Apr 10;10(4):e0122961. doi: 10.1371/journal.pone.0122961. eCollection 2015.

2.

The Fibroblast Growth Factor signaling pathway.

Ornitz DM, Itoh N.

Wiley Interdiscip Rev Dev Biol. 2015 May-Jun;4(3):215-66. doi: 10.1002/wdev.176. Epub 2015 Mar 13.

3.

Bile acids, obesity, and the metabolic syndrome.

Ma H, Patti ME.

Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):573-83. doi: 10.1016/j.bpg.2014.07.004. Epub 2014 Jul 11. Review.

PMID:
25194176
4.

Development of a chemically defined medium and discovery of new mitogenic growth factors for mouse hepatocytes: mitogenic effects of FGF1/2 and PDGF.

Bowen WC, Michalopoulos AW, Orr A, Ding MQ, Stolz DB, Michalopoulos GK.

PLoS One. 2014 Apr 17;9(4):e95487. doi: 10.1371/journal.pone.0095487. eCollection 2014.

5.

Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice.

Zhang L, Wang YD, Chen WD, Wang X, Lou G, Liu N, Lin M, Forman BM, Huang W.

Hepatology. 2012 Dec;56(6):2336-43. doi: 10.1002/hep.25905.

6.

SRC-3 is required for CAR-regulated hepatocyte proliferation and drug metabolism.

Chen T, Chen Q, Xu Y, Zhou Q, Zhu J, Zhang H, Wu Q, Xu J, Yu C.

J Hepatol. 2012 Jan;56(1):210-7. doi: 10.1016/j.jhep.2011.07.015. Epub 2011 Aug 7.

7.

Animal models for the study of liver fibrosis: new insights from knockout mouse models.

Hayashi H, Sakai T.

Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G729-38. doi: 10.1152/ajpgi.00013.2011. Epub 2011 Feb 24. Review.

8.

Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation.

Pan RL, Wang P, Xiang LX, Shao JZ.

J Biol Chem. 2011 Apr 8;286(14):12340-8. doi: 10.1074/jbc.M110.194498. Epub 2011 Jan 14.

9.

The Role of PPARα Activation in Liver and Muscle.

Burri L, Thoresen GH, Berge RK.

PPAR Res. 2010;2010. pii: 542359. doi: 10.1155/2010/542359. Epub 2010 Aug 18.

10.

Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.

Luo Y, Yang C, Lu W, Xie R, Jin C, Huang P, Wang F, McKeehan WL.

J Biol Chem. 2010 Sep 24;285(39):30069-78. doi: 10.1074/jbc.M110.148288. Epub 2010 Jul 23.

11.

FGF receptors 1 and 2 control chemically induced injury and compound detoxification in regenerating livers of mice.

Böhm F, Speicher T, Hellerbrand C, Dickson C, Partanen JM, Ornitz DM, Werner S.

Gastroenterology. 2010 Oct;139(4):1385-96. doi: 10.1053/j.gastro.2010.06.069. Epub 2010 Aug 7.

12.

FXR regulates liver repair after CCl4-induced toxic injury.

Meng Z, Wang Y, Wang L, Jin W, Liu N, Pan H, Liu L, Wagman L, Forman BM, Huang W.

Mol Endocrinol. 2010 May;24(5):886-97. doi: 10.1210/me.2009-0286. Epub 2010 Mar 8.

13.

Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.

Song KH, Li T, Owsley E, Strom S, Chiang JY.

Hepatology. 2009 Jan;49(1):297-305. doi: 10.1002/hep.22627.

14.

The protective role of Per2 against carbon tetrachloride-induced hepatotoxicity.

Chen P, Li C, Pang W, Zhao Y, Dong W, Wang S, Zhang J.

Am J Pathol. 2009 Jan;174(1):63-70. doi: 10.2353/ajpath.2009.080430. Epub 2008 Dec 4.

15.

Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis.

Huang X, Yang C, Jin C, Luo Y, Wang F, McKeehan WL.

Mol Carcinog. 2009 Jun;48(6):553-62. doi: 10.1002/mc.20494.

16.

Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway.

Zhao P, Caretti G, Mitchell S, McKeehan WL, Boskey AL, Pachman LM, Sartorelli V, Hoffman EP.

J Biol Chem. 2006 Jan 6;281(1):429-38. Epub 2005 Nov 2.

17.

Protective effect of fufanghuangqiduogan against acute liver injury in mice.

Gui SY, Wei W, Wang H, Wu L, Sun WY, Wu CY.

World J Gastroenterol. 2005 May 21;11(19):2984-9.

18.

Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease.

Steiling H, Mühlbauer M, Bataille F, Schölmerich J, Werner S, Hellerbrand C.

Am J Pathol. 2004 Oct;165(4):1233-41.

19.

Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis.

Yu C, Wang F, Jin C, Huang X, Miller DL, Basilico C, McKeehan WL.

Am J Pathol. 2003 Oct;163(4):1653-62.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk